Hector Rodriguez Jr, MD in West Columbia, SC - Medicare Allergy/immunology

Hector Rodriguez Jr, MD is a medicare enrolled "Allergy & Immunology" physician in West Columbia, South Carolina. He went to University Of South Carolina School Of Medicine and graduated in 2010 and has 14 years of diverse experience with area of expertise as Allergy/immunology. He is a member of the group practice Allergy Partners Pllc and his current practice location is 103 Midlands Ct, West Columbia, South Carolina. You can reach out to his office (for appointments etc.) via phone at (803) 794-3581.

Hector Rodriguez Jr is licensed to practice in South Carolina (license number MD38380) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1013233097.

Contact Information

	Hector Rodriguez Jr, MD
	103 Midlands Ct, West Columbia, SC 29169-3456
	(803) 794-3581
	(803) 791-7286

Physician's Profile

Full Name	Hector Rodriguez Jr
Gender	Male
Speciality	Allergy/immunology
Experience	14 Years
Location	103 Midlands Ct, West Columbia, South Carolina
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Hector Rodriguez Jr attended and graduated from University Of South Carolina School Of Medicine in 2010

NPI Data:

NPI Number: 1013233097
Provider Enumeration Date: 04/15/2010
Last Update Date: 10/31/2023

Medicare PECOS Information:

PECOS PAC ID: 1254647035
Enrollment ID: I20150825004940

Medical Identifiers

Medical identifiers for Hector Rodriguez Jr such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013233097	NPI	-	NPPES
SC62386874	Other	SC	MEDICARE PTAN
383800	Medicaid	SC

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207K00000X	Allergy & Immunology	38380 (South Carolina)	Secondary
207K00000X	Allergy & Immunology	MD38380 (South Carolina)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Allergy Partners Pllc	7113822420	149

News Archive

HPV vaccine policies may lead to higher vaccination rates, reduce cancer rates

A UCLA-led study has found that in 2 of 3 states and jurisdictions with policies that require students entering school to receive the human papillomavirus vaccine, vaccination rates among 13-to-17-year-olds were significantly higher than in surrounding states without such policies.

IBRI receives $1 million research grant from Cook Medical to support growth of Institute

The Indiana Biosciences Research Institute (IBRI) today announced a $1 million research grant from Cook Medical to support the next phase of growth for the Institute dedicated to discovery science and applied research leading to innovation targeting cardio-metabolic disease, diabetes, and poor nutrition.

Alcon's PATANASE nasal spray approved by FDA for treatment of nasal allergy symptoms

Alcon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved PATANASE(R) (olopatadine hydrochloride) nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older.

Research team reports advances in development of an effective therapy against the Nipah and Hendra virus

A collaborative research team from the Uniformed Services University of the Health Sciences (USU), the Australian Animal Health Laboratory (AAHL), and the National Cancer Institute (NCI), National Institutes of Health (NIH) reports a major step forward in the development of an effective therapy against two deadly viruses, Nipah virus and the related Hendra virus.

Malaria drug does not prevent infection of human lung cells with novel coronavirus

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Hector Rodriguez Jr allows following entities to bill medicare on his behalf.

Entity Name	Allergy Partners Pllc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1538101258 PECOS PAC ID: 7113822420 Enrollment ID: O20050623000563

News Archive

HPV vaccine policies may lead to higher vaccination rates, reduce cancer rates

IBRI receives $1 million research grant from Cook Medical to support growth of Institute

Alcon's PATANASE nasal spray approved by FDA for treatment of nasal allergy symptoms

Research team reports advances in development of an effective therapy against the Nipah and Hendra virus

Malaria drug does not prevent infection of human lung cells with novel coronavirus

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Hector Rodriguez Jr is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Hector Rodriguez Jr, MD Po Box 603725, Charlotte, NC 28260-3725 Ph: (828) 575-2625	Hector Rodriguez Jr, MD 103 Midlands Ct, West Columbia, SC 29169-3456 Ph: (803) 794-3581

News Archive

HPV vaccine policies may lead to higher vaccination rates, reduce cancer rates

IBRI receives $1 million research grant from Cook Medical to support growth of Institute

Alcon's PATANASE nasal spray approved by FDA for treatment of nasal allergy symptoms

Research team reports advances in development of an effective therapy against the Nipah and Hendra virus

Malaria drug does not prevent infection of human lung cells with novel coronavirus

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).

Allergy & Immunology Doctors in West Columbia, SC

Roy Douglass Markham, M. D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 103 Midlands Ct, West Columbia, SC 29169 Phone: 803-794-3581 Fax: 803-791-7286
Dewitt Mcintyre Coleman Jr., M. D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 103 Midlands Ct, West Columbia, SC 29169 Phone: 803-794-3581 Fax: 803-791-7286
Laura Waikart Dougherty, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 103 Midlands Ct, West Columbia, SC 29169 Phone: 803-794-3581 Fax: 803-791-7286
Dr. Barbara Ellen Magera, MD, PHARM. D Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 2720 Sunset Blvd, West Columbia, SC 29169 Phone: 803-791-2480 Fax: 803-936-4102

Hector Rodriguez Jr, MD - Medicare Allergy/immunology in West Columbia, SC

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

HPV vaccine policies may lead to higher vaccination rates, reduce cancer rates

IBRI receives $1 million research grant from Cook Medical to support growth of Institute

Alcon's PATANASE nasal spray approved by FDA for treatment of nasal allergy symptoms

Research team reports advances in development of an effective therapy against the Nipah and Hendra virus

Malaria drug does not prevent infection of human lung cells with novel coronavirus

Medicare Reassignments

HPV vaccine policies may lead to higher vaccination rates, reduce cancer rates

IBRI receives $1 million research grant from Cook Medical to support growth of Institute

Alcon's PATANASE nasal spray approved by FDA for treatment of nasal allergy symptoms

Research team reports advances in development of an effective therapy against the Nipah and Hendra virus

Malaria drug does not prevent infection of human lung cells with novel coronavirus

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

HPV vaccine policies may lead to higher vaccination rates, reduce cancer rates

IBRI receives $1 million research grant from Cook Medical to support growth of Institute

Alcon's PATANASE nasal spray approved by FDA for treatment of nasal allergy symptoms

Research team reports advances in development of an effective therapy against the Nipah and Hendra virus

Malaria drug does not prevent infection of human lung cells with novel coronavirus

Allergy & Immunology Doctors in West Columbia, SC